IDH1 and acute myeloid leukemia: In AML, IDH1-mutant preleukemic hematopoietic stem cells (pHSCs) display impaired differentiation and a transcriptional signature distinct from both healthy HSCs and fully transformed leukemic stem cells (LSCs).